Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 123

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 123
---
 creditors, contractors and other persons with whom Aadi Sub has business relations.           |

Aadi and Aadi Sub have also agreed that they will use their commercially reasonable efforts (1) to ensure that all insurance policies and state licenses in effect as of the date of the Divestiture Agreement remain in effect and, with respect to such insurance policies and licenses as may expire from the date of the Divestiture Agreement to the completion of the Divestiture (or termination of the Divestiture Agreement), to renew or replace such insurance policies or licenses, in each case on terms not materially less favorable as the insurance policies or licenses in effect as of the date of the Divestiture Agreement; and (2) to cooperate with Kaken, at Kaken’s expense, as may be necessary to enable Aadi Sub to obtain its own similar policies or licenses and/or obtain the material benefits following the completion of the Divestiture from the insurance policies and/or licenses, whether such insurance policies or licenses are held in the name of Aadi, Aadi Sub or otherwise. Aadi and Aadi Sub have also agreed that, subject to certain exceptions set forth in the Divestiture Agreement, they will not:

| • |     | amend either Aadi or Aadi Sub’s organizational documents; |

| • |     | propose or adopt a plan of complete or partial liquidation, dissolution, merger, consolidation, restructuring, 
 recapitalization, conversion, division or other reorganization;                                                |

| • |     | issue, sell, or deliver, or agree or commit to issue, sell or deliver, any shares of capital stock of, or other                                                                                                                                          
 equity or voting interest, restricted stock, restricted stock units, stock appreciation rights, performance shares, contingent value rights, “phantom” stock or similar securities or rights that are derivative of, or provide economic                 
 benefits based, directly or indirectly, on the value or price of, any capital stock of, or other securities or ownership interests in, Aadi Sub, or any security convertible into or exchangeable for any of the foregoing (whether through the issuance 
 or granting of options, warrants, commitments, subscriptions, rights to purchase or otherwise);                                                                                                                                                          |

| • |     | issue, sell, or deliver, or agree or commit to issue, sell or deliver, any shares of capital stock of, or other                                                                                                                                      
 equity or voting interest in, Aadi (whether through the issuance or granting of options, warrants, commitments, subscriptions, rights to purchase or otherwise) to